Clinical significance of Angiopoietin-1 in Behcet’s disease patients with vascular involvement
- 12 May 2015
- journal article
- Published by Springer Nature in Heart and Vessels
- Vol. 31 (6) , 918-924
Abstract
Behcet’s disease (BD) is a chronic multisystem inflammatory disorder of unclear etiology. Vascular inflammation, endothelial dysfunction and angiogenesis may be in part responsible for the pathogenesis of BD. Angiopoietin-1 (Ang-1) is a recent angiogenic mediator. The aim of the present study was to assess Ang-1 in the plasma of BD patients as well as to analyze its association with clinical, and laboratory parameters of the disease. The present study included 47 BD patients and 30 age- and gender-matched healthy controls. Demographic, clinical, disease activity and severity were prospectively assessed. Plasma Ang-1 levels were measured using enzyme-linked immunosorbent assay. The plasma level of Ang-1 in BD patients was significantly lower than healthy controls (p = 0.005). Plasma Ang-1 level in patients with vascular affection was significantly lower than those without vascular affection (p = 0.045). Levels of Ang-1 showed a significant positive correlation with steroid dose. Patients who received cyclophosphamide or steroids showed a significant increase in plasma Ang-1 level. This was further confirmed by the results of the multivariate analysis. There was no significant association between plasma Ang-1 levels and other clinical manifestations or disease activity and severity. Plasma Ang-1 levels were diminished in our BD patients especially in patients with vascular involvement. Larger studies with further investigations of the precise role of Ang-1 in the pathogenesis of BD are needed and might lead to novel therapies for the clinical management of BDKeywords
This publication has 33 references indexed in Scilit:
- VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF SyxJournal of Cell Biology, 2012
- Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsisCritical Care, 2012
- Molecular control of angiopoietin signallingBiochemical Society Transactions, 2011
- Angiopoietin-1 Gene Therapy Attenuates Hypertension and Target Organ Damage in Nitric Oxide Synthase Inhibited Spontaneously Hypertensive RatsKorean Circulation Journal, 2011
- Hypertension, Vascular Rarefaction and Angiopoietin-1Korean Circulation Journal, 2011
- Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvementNephrology Dialysis Transplantation, 2009
- Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulationClinical Rheumatology, 2007
- Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell traffickingJournal of Leukocyte Biology, 2006
- Signaling and Functions of Angiopoietin-1 in Vascular ProtectionCirculation Research, 2006
- Plasma Angiopoietin-1, Angiopoietin-2, Angiopoietin Receptor Tie-2, and Vascular Endothelial Growth Factor Levels in Acute Coronary SyndromesCirculation, 2004